Sriram Krishnamurthy Peruvemba - 03 Sep 2025 Form 4 Insider Report for SmartKem, Inc. (SMTK)

Reporting relationship: Director
Issuer ticker: SMTK
Reported as of: 03 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Sep 2025, 18:00:10 UTC
Prior SEC filing: 27 Jun 2025
Next SEC filing: 26 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Barbra Keck, attorney-in-fact for Sriram Krishnamurthy Peruvemba

Key filing fact

Sriram Krishnamurthy Peruvemba filed Form 4 for SmartKem, Inc. (SMTK) on 05 Sep 2025.

Key facts

This page summarizes Sriram Krishnamurthy Peruvemba's Form 4 filing for SmartKem, Inc. (SMTK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Sep 2025, 18:00.

Change

Previous filing in this sequence was filed on 27 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001656093 Primary reporting owner

Peruvemba Sriram Krishnamurthy

Relationship: Director
Address: C/O SMARTKEM, MANCHESTER TECHNOLOGY CTR, HEXAGON TOWER DELAUNAYS ROAD, BLACKLEY, MANCHESTER, UNITED KINGDOM
Signature: /s/ Barbra Keck, attorney-in-fact for Sriram Krishnamurthy Peruvemba
Signature date: 05 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SMTK transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +22,466
Change %
Price: $0.000000
Shares after: 22,466
Date: 03 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,466
Exercise price: $1.16
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests as follows: 25% on the date of grant with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on September 3, 2025 and on the 3rd date of each month thereafter.